US Supreme Court has resumed access to mifepristone abortion pill via mail, pharmacies and telehealth

The US Supreme Court's decision to resume access to the mifepristone abortion pill reflects ongoing tensions in the national debate over reproductive rights, which could influence voter sentiment heading into the upcoming elections. This access via mail and pharmacies may prompt reactions from various sectors, including healthcare and pharmaceuticals, as well as impact state-level policies and legislation. Investors should consider the potential volatility in related stocks and the broader implications for social policy in the US.